Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cucurbita pepo extract is derived from the seeds and sometimes other parts of the Cucurbita pepo plant, commonly known as pumpkin. It is used in traditional and herbal medicine for its potential effects on urinary tract and genital disorders, particularly benign prostatic hyperplasia (BPH), bladder irritation, and as an anthelmintic agent. The main active constituents include fatty oils, proteins, phytosterols (such as beta-sitosterol), tocopherols, cucurbitin (an amino acid with anthelmintic properties), and various antioxidants[1][3][5]. Clinical data are limited but suggest possible benefits for BPH symptoms; however, robust evidence is lacking. The mechanism of action may involve diuretic effects from increased urination due to phytochemicals in the seeds[6]. There are no well-documented severe adverse reactions or drug interactions except a possible interaction with lithium due to diuretic effects[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cucurbita pepo extract.